(continued)
- FDA OKs Drug for Insatiable Hunger in Prader-Willi Syndrome
- FDA Green-Lights First New Antibiotic for UTIs in Nearly 30 Years
- FDA OKs Novel Treatment for Life-Threatening Heart Condition
- FDA OKs New Crohn’s Treatment You Can Inject at Home
- FDA OKs First Treatment for Rare Kidney Disease
- FDA OKs First Myasthenia Gravis Treatment for Children
- FDA OKs First Gene Therapy Implant for a Rare Eye Disease
- FDA OKs Nasal Spray for Severe Allergic Reactions in Kids
- FDA Approves New Treatment for Stroke
- FDA Approves New Label for Opioid Use Disorder Drug
- FDA Approves New Treatment for Rare Lipid Storage Disease
- FDA OKs First Fast-Acting Insulin Biosimilar for Diabetes
- FDA OKs Vaccine for Mosquito-Borne Chikungunya
- FDA Approves New Drug for Rare Joint Tumor
- FDA Approves 5-in-1 Vaccine Against Meningococcal Disease
- FDA OKs Triple Combo for Advanced Large B-Cell Lymphoma
- FDA Approves New Treatment for NF1-Related Tumors
- FDA OKs New Antibiotic Combo for Serious Abdominal Infections
- FDA OKs Implantable Treatment for Diabetic Macular Edema
- FDA OKs New Wearable Infusion Device for Parkinson’s
- FDA Approves New Drug Combination for Mantle Cell Lymphoma
- FDA Approves New Non-Opioid Pain Treatment
- FDA OKs Ozempic for Kidney Disease in Diabetes Patients
- FDA Approves Drug for Hard-to-Treat Breast Cancer
- FDA Approves New Prep Regimen for Bone Marrow Transplant
- FDA Approves New Treatment for Advanced Breast Cancer
- FDA Approves Omvoh for Crohn’s Disease
- FDA Approves Zepbound for Obstructive Sleep Apnea
- FDA OKs First Treatment for Familial Chylomicronemia Syndrome
- FDA Approves New Drug for Kids With Severe Immune Disease